Unusual bevacizumab-related complication of an oral infection.
Department of Oral and Maxillofacial Surgery, Saint-Luc University Hospital and Cancer Center, Université Catholique de Louvain, Brussels, Belgium. magremanne.michele@gmail.com
Michèle
M
Magremanne
Morgan
M
Lahon
Joke
J
De Ceulaer
Hervé
H
Reychler
D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D000068258:Bevacizumab; D059266:Bisphosphonate-Associated Osteonecrosis of the Jaw / Q000209:etiology*; D001932:Brain Neoplasms / Q000473:pathology* / Q000601:surgery; D016972:Enterobacter cloacae; D004756:Enterobacteriaceae Infections / Q000382:microbiology; D005145:Face / Q000098:blood supply; D017809:Fatal Outcome; D005909:Glioblastoma / Q000473:pathology* / Q000601:surgery; D006801:Humans; D008297:Male; D008340:Mandibular Nerve / Q000473:pathology; D008875:Middle Aged; D009336:Necrosis / Q000209:etiology / Q000473:pathology; D010508:Periodontal Abscess / Q000188:drug therapy*; D011994:Recombinant Proteins; D013203:Staphylococcal Infections / Q000382:microbiology; D013530:Surgical Wound Infection / Q000382:microbiology / Q000601:surgery*; D013702:Temporal Lobe / Q000601:surgery
D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D011994:Recombinant Proteins; D000068258:Bevacizumab